# James Brugarolas

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/james-brugarolas/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,648 |
| Field | Renal cell carcinoma treatment |
| h-index | 65 |
| i10-index | 163 |
| Last Known Institution | Texas Oncology |
| OpenAlex ID | https://openalex.org/A5046541559 |
| ORCID iD | https://orcid.org/0000-0002-8575-499X |
| Works | 640 |

## Researcher papers

- [BAP1 loss defines a new class of renal cell carcinoma](https://scholariq.org/papers/bap1-loss-defines-a-new-class-of-renal-cell-carcinoma/)
- [A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma](https://scholariq.org/papers/a-validated-tumorgraft-model-reveals-activity-of-dovitinib-against-renal-cell/)

## Researcher topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

## Researcher university

- [Texas Oncology](https://scholariq.org/institutions/texas-oncology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.